Collections

  • Collection |

    The American Society of Gene and Cell Therapy Annual Meeting is upon us, 29th April - 2nd May 2019 and will focus on new developments and advancements in the field of gene and cell therapy research over the last year. The Editor-in-Chief of GT, in the spirit of this important event, is pleased to showcase the work of many researchers in this field, which align with the critical themes of this exciting congress.

  • Collection |

    See what scientists world-wide have been citing, reading and sharing. In this Web Collection we highlight a selection of articles from 2017 and 2018 which top the list of the journal's most cited, most read and most shared (including press coverage and Twitter). They showcase the breadth of scope and coverage that Gene Therapy consistently delivers to its readers.

    Image: ALFRED PASIEKA/SCIENCE PHOTO LIBRARY
  • Collection |

    The Editor-in-Chief of Gene Therapy is delighted to share with you an Editor's Choice selection of key papers that highlight some of the best current research published in the journal. These papers showcase the breadth of scope and coverage that Gene Therapy consistently deliver to its readers, and have been selected because readers of the journal will find them particularly interesting or useful.

  • Special |

    The Spinraza and Advanced Therapies: a stakeholder special issue of Gene Therapy covers a variety of perspectives and includes comments and review papers from SMA research funders, people affected, experts in the advanced therapies field, SMA scientists and clinicians, regulators, ethics and pricing/IP experts, and community stakeholders.

  • Focus |

    The science of gene therapy is enjoying a renaissance after ups and downs over the past 25 years. The heart of this field still largely relies on viral vector gene transfer systems that have evolved considerably. There is now a wealth of clinical experience with numerous vector types that have been applied primarily to treatment of cancer and rare metabolic diseases. Viral vectors will likely achieve considerable prominence in the delivery of gene editing tools, providing an important aspect of gene therapy strategies going forward. Still more advanced platforms and vehicle delivery systems are required to enable appropriate level and duration of gene expression in targeted cell types. Recent research into the field of vector technologies are highlighted in publications in the journal Gene Therapy.